Potassium-Containing Salt-Substitute in End Stage Kidney Disease

This study is looking at how a special salt substitute affects potassium levels in people with end-stage kidney disease who are on hemodialysis. The salt substitute has about 50% less sodium than regular table salt because it uses potassium chloride instead of sodium chloride. You would try both the Salt Substitute and Standard Table Salt for 16 days each, with a break in between. Researchers will measure your potassium levels to see if the salt substitute changes them. They will also look at your diet, blood pressure, and any symptoms you might have. To join, you need to be at least 21 years old and receiving outpatient hemodialysis. Your serum potassium level must not be above 6. The study plans to enroll 20 participants, but the current status of enrollment is unclear.

Study design
This interventional study involves 16 participants who will receive both a potassium-containing salt substitute and standard table salt in a random order.
What's involved
You would use the Salt Substitute for 16 days and Standard Table Salt for 16 days, with a 19-day break in between. Potassium levels will be measured twice a week before your dialysis sessions.
Compensation
Not stated in the trial record.
Follow-up
Potassium levels will be measured during the two 16-day treatment periods, with measurements at Day 1, Day 16, Day 36, and Day 52.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05558267

Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

Not Yet Recruiting
NAAges 21+InterventionalPrevention
NYU Langone Health
~20 participants
Updated 2026-03-12 on ClinicalTrials.gov
What's tested:Standard Table SaltSalt Substitute

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Serum Potassium Concentration During First Treatment Period
Measured over Day 1, Day 16
+1 more outcome measured
End Stage Kidney Disease
1 sites across 1 states
New York1
  • David Charytan, MD MSc · PRINCIPAL_INVESTIGATOR · NYU Langone Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Change in Serum Potassium Concentration During First Treatment PeriodDay 1, Day 16

    Serum potassium concentration expressed in milliequivalents per liter (mEq/L).

  • Change in Serum Potassium Concentration During Second Treatment PeriodDay 36, Day 52

    Serum potassium concentration expressed in mEq/L.